01766nam a2200337Ia 4500001001200000003000800012006001900020007001500039008004100054020001800095020001500113040002100128035002100149050002400170110014500194245041000339260005100749300001800800504005100818533015200869650002801021650002801049655002901077700003801106700002001144710006801164710003601232710001701268856012601285999001701411ebr10606357CaPaEBRm        u        cr cn|||||||||120711s2012    dcu     sb    001 0 eng d  z9780309225496  z0309225493  aCaPaEBRcCaPaEBR  a(OCoLC)81328577114aRJ560b.C666 2012eb2 aCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)10aSafe and effective medicines for childrenh[electronic resource] :bpediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /cCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.  aWashington :bNational Academies Press,c2012.  axxiii, 408 p.  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPediatric pharmacology. 0aDrugsxSafety measures. 7aElectronic books.2local1 aField, Marilyn J.q(Marilyn Jane)1 aBoat, Thomas F.2 aInstitute of Medicine (U.S.).bBoard on Health Sciences Policy.2 aNational Academies Press (U.S.)2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10606357zAn electronic book accessible through the World Wide Web; click to view  c97266d97266